Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Project EMPOWERING: PrEP for Justice-Involved Women
NCT03293290Phase 1Completed
- Sponsor
- Yale University
- Start
- Dec 2017
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Yale University. Primary endpoints: Percentage of PrEP uptake at 1 month and Percentage of eligible PrEP uptake at 1 month. Started Dec 2017; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03293290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03293290.